Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network
Ophthalmology (Rochester, Minn.), 2022-05, Vol.129 (5), p.520 [Peer Reviewed Journal]Copyright © 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2021.11.013 ;PMID: 34793830
Digital Resources/Online E-Resources